Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

U.S. Supreme Court rebuffs UnitedHealth Group challenge on Medicare overpayments

Published 06/21/2022, 09:44 AM
Updated 06/21/2022, 10:37 AM
© Reuters. FILE PHOTO: UnitedHealth Group's headquarters building is seen in Minnetonka, Minnesota, U.S. in this handout picture taken in 2019. UnitedHealth Group/Handout via REUTERS/File Photo

By Brendan Pierson

(Reuters) -The U.S. Supreme Court on Tuesday declined to hear UnitedHealth Group Inc (NYSE:UNH)'s challenge to a government rule requiring private insurers that administer federally funded Medicare plans to return potentially billions of dollars in overpayments they receive based on incorrect diagnoses.

Turning away the Minnetonka, Minnesota-based insurer's appeal, the justices left in place a lower court's decision reviving the rule after a federal judge had previously struck it down.

UnitedHealth said in a statement that it would continue to comply with federal rules and "remain focused on providing high quality and affordable healthcare to millions of seniors."

The 2014 rule applies to so-called Medicare Advantage insurance plans, which are funded through the U.S. Department of Health and Human Services (HHS) but administered by private insurers like UnitedHealth. HHS pays Medicare Advantage plans a base amount per beneficiary, adjusted according to diagnostic codes reflecting each beneficiary's individual risk factors.

Under the rule, if a Medicare Advantage insurer learns that it received a payment based on an unsupported diagnosis, it must return that payment within 60 days.

According to a 2016 federal audit, the government paid out about $16.2 billion that year based on unsupported diagnoses, nearly 10% of the total paid to Medicare Advantage insurers.

In its 2016 lawsuit, UnitedHealth argued that the overpayment rule treated Medicare Advantage differently from traditional Medicare, which pays providers on a fee-for-service basis and does not comprehensively audit claims for overpayments. The insurer said the difference ran afoul of the Medicare law's requirement of "actuarial equivalence" between Medicare Advantage and traditional Medicare.

U.S. District Judge Rosemary Collyer in Washington agreed, overturning the rule in 2018. But the U.S. Court of Appeals for the District of Columbia Circuit last year concluded that Congress never intended to free insurers of their obligation to return overpayments when it passed the actuarial equivalence requirement, restoring the rule.

© Reuters. FILE PHOTO: UnitedHealth Group's headquarters building is seen in Minnetonka, Minnesota, U.S. in this handout picture taken in 2019. UnitedHealth Group/Handout via REUTERS/File Photo

HHS did not immediately respond to a request for comment.

AHIP, a health insurance trade group that does not include UnitedHealth, submitted a brief to the Supreme Court supporting the insurer, as did the U.S. Chamber of Commerce business group and America's Physician Groups, a national physician group association.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.